• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions

tetano

Editor, Senior Moderator
Front Immunol


. 2021 Oct 4;12:741502.
doi: 10.3389/fimmu.2021.741502. eCollection 2021.
Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions


Mai M Abdelmoaty[SUP] 1 2 [/SUP], Pravin Yeapuri[SUP] 1 [/SUP], Jatin Machhi[SUP] 3 [/SUP], Katherine E Olson[SUP] 3 [/SUP], Farah Shahjin[SUP] 3 [/SUP], Vikas Kumar[SUP] 4 [/SUP], You Zhou[SUP] 5 [/SUP], Jingjing Liang[SUP] 6 [/SUP], Kabita Pandey[SUP] 3 [/SUP], Arpan Acharya[SUP] 3 [/SUP], Siddappa N Byrareddy[SUP] 3 [/SUP], R Lee Mosley[SUP] 3 [/SUP], Howard E Gendelman[SUP] 3 [/SUP]



Affiliations

Abstract

Host innate immune response follows severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and it is the driver of the acute respiratory distress syndrome (ARDS) amongst other inflammatory end-organ morbidities. Such life-threatening coronavirus disease 2019 (COVID-19) is heralded by virus-induced activation of mononuclear phagocytes (MPs; monocytes, macrophages, and dendritic cells). MPs play substantial roles in aberrant immune secretory activities affecting profound systemic inflammation and end-organ malfunctions. All follow the presence of persistent viral components and virions without evidence of viral replication. To elucidate SARS-CoV-2-MP interactions we investigated transcriptomic and proteomic profiles of human monocyte-derived macrophages. While expression of the SARS-CoV-2 receptor, the angiotensin-converting enzyme 2, paralleled monocyte-macrophage differentiation, it failed to affect productive viral infection. In contrast, simple macrophage viral exposure led to robust pro-inflammatory cytokine and chemokine expression but attenuated type I interferon (IFN) activity. Both paralleled dysregulation of innate immune signaling pathways, specifically those linked to IFN. We conclude that the SARS-CoV-2-infected host mounts a robust innate immune response characterized by a pro-inflammatory storm heralding end-organ tissue damage.

Keywords: SARS-CoV-2; cytokine storm; end-organ disease; inflammation; interferon; macrophages; proteomics; transcriptomics.
 
Back
Top Bottom